TY - JOUR AU - Kola, I. AU - Landis, J. PY - 2004 DA - 2004// TI - Can the pharmaceutical industry reduce attrition rates? JO - Nat Rev Drug Discov VL - 3 UR - https://doi.org/10.1038/nrd1470 DO - 10.1038/nrd1470 ID - Kola2004 ER - TY - STD TI - Parexel's Pharmaceutical R&D Statistical Sourcebook. [http://www.parexel.com/products_services/publications.asp] UR - http://www.parexel.com/products_services/publications.asp ID - ref2 ER - TY - BOOK PY - 2004 DA - 2004// TI - Innovation Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products ID - ref3 ER - TY - JOUR AU - Roses, A. PY - 2002 DA - 2002// TI - Genome-based pharmacogenetics and the pharmaceutical industry JO - Nat Rev Drug Discov VL - 1 UR - https://doi.org/10.1038/nrd840 DO - 10.1038/nrd840 ID - Roses2002 ER - TY - JOUR AU - Frank, R. AU - Hargreaves, R. PY - 2003 DA - 2003// TI - Clinical biomarkers in drug discovery and development JO - Nat Rev Drug Discov VL - 2 UR - https://doi.org/10.1038/nrd1130 DO - 10.1038/nrd1130 ID - Frank2003 ER - TY - JOUR AU - Lang, P. AU - Yeow, K. AU - Nichols, A. AU - Scheer, A. PY - 2006 DA - 2006// TI - Cellular imaging in drug discovery JO - Nat Rev Drug Discov VL - 5 UR - https://doi.org/10.1038/nrd2008 DO - 10.1038/nrd2008 ID - Lang2006 ER - TY - JOUR AU - Pritchard, J. F. AU - Jurima-Romet, M. AU - Reimer, M. AU - Mortimer, E. AU - Rolfe, B. AU - Cayen, M. PY - 2003 DA - 2003// TI - Making better drugs: decision gates in non-clinical drug development JO - Nat Rev Drug Discov VL - 2 UR - https://doi.org/10.1038/nrd1131 DO - 10.1038/nrd1131 ID - Pritchard2003 ER -